GlassScriptPhysician profile
Bernadette M Hoffmann
NPI 1275876831
$4,612.00
in general payments reported to CMS, 2019-2025
26 companies · $988 in 2025
The $988 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $713 · 2022: $1,162 · 2023: $873 · 2024: $875 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,736.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $901.25 | 2022-2025 | Airsupra, Fasenra, Andexxa |
| Pfizer INC. | $764.28 | 2021-2025 | |
| Gilead Sciences, INC. | $335.84 | 2021-2025 | Epclusa, Descovy |
| Acadia Pharmaceuticals INC | $303.35 | 2022-2023 | Nuplazid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.07 | 2024 | Jardiance |
| Amgen INC. | $232.05 | 2024-2025 | Repatha, Repatha, Otezla |
| Urovant Sciences INC | $187.80 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.00 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $125.33 | 2022 | |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $124.68 | 2022 | |
| Lilly USA, LLC | $120.83 | 2023 | Mounjaro |
| Esperion Therapeutics, INC. | $111.35 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.78 | 2025 | Caplyta |
| Insmed, INC. | $100.80 | 2023 | Arikayce |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.20 | 2022 | |
| Laborie Medical Technologies Corp. | $93.12 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Paratek Pharmaceuticals, INC. | $90.29 | 2022 | |
| Inspire Medical Systems, INC. | $90.25 | 2023 | Inspire |
| Boston Scientific Corporation | $77.27 | 2021 | |
| Abbott Laboratories | $67.66 | 2023 | Freestyle Libre 3 |
| Coloplast Corp | $55.59 | 2024 | |
| Abbvie INC. | $46.74 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $36.36 | 2021 | |
| Eisai INC. | $26.05 | 2024 | |
| Grt US Holding, INC. | $17.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernadette Hoffmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.